Key Points
- Insider sale: Doximity insider Siddharth Sitaram sold 2,309 shares at an average price of $25.77, totaling about $59,503. The trade was made under a pre-arranged 10b5-1 plan and was tied to tax withholding from vesting equity awards.
- Earnings and guidance were mixed: Doximity beat one adjusted EPS estimate at $0.26 and grew revenue 5.1% year over year to $145.37 million, but it missed broader consensus expectations. Its first-quarter and full-year FY2027 revenue guidance also came in below forecasts, which may have pressured the stock.
- Analyst and ownership backdrop: Wall Street sentiment remains cautious but constructive, with a consensus rating of Moderate Buy and a $33.20 price target. Institutional investors still own the majority of the stock, with 87.19% held by funds and institutions.
Doximity, Inc. (NYSE:DOCS - Get Free Report) insider Siddharth Sitaram sold 2,309 shares of Doximity stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $25.77, for a total transaction of $59,502.93. Following the completion of the sale, the insider owned 89,396 shares of the company's stock, valued at $2,303,734.92. This trade represents a 2.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Siddharth Sitaram also recently made the following trade(s):
- On Friday, April 10th, Siddharth Sitaram sold 2,427 shares of Doximity stock. The stock was sold at an average price of $21.09, for a total transaction of $51,185.43.
- On Tuesday, March 10th, Siddharth Sitaram sold 2,319 shares of Doximity stock. The stock was sold at an average price of $25.37, for a total transaction of $58,833.03.
Doximity Stock Down 11.1%
DOCS stock opened at $23.52 on Thursday. The stock has a 50 day moving average of $24.27. The firm has a market cap of $4.34 billion, a PE ratio of 19.60, a PEG ratio of 1.88 and a beta of 1.36. Doximity, Inc. has a 52 week low of $20.55 and a 52 week high of $76.51.
Doximity announced that its board has approved a share repurchase program on Thursday, February 5th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 8% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's leadership believes its shares are undervalued.
Key Stories Impacting Doximity
Here are the key news stories impacting Doximity this week:
- Positive Sentiment: Doximity reported adjusted earnings of $0.26 per share, beating the lower analyst estimate of $0.17, and revenue rose 5.1% year over year to $145.37 million, showing the business is still growing. Doximity Earnings Report
- Neutral Sentiment: The company’s high margin profile remained intact, with a 23.84% return on equity and 37.54% net margin, suggesting continued operational efficiency. Fiscal Q4 Earnings Snapshot
- Negative Sentiment: Despite the earnings beat versus one estimate, Doximity missed the broader Zacks consensus of $0.28 per share, which may have disappointed traders looking for a stronger beat. Doximity Lags Q4 Earnings Estimates
- Negative Sentiment: More importantly for investors, Doximity’s first-quarter FY2027 revenue guidance of $151 million to $152 million came in below the $153.2 million consensus, and full-year FY2027 revenue guidance of $664 million to $676 million also missed the $696 million estimate, signaling a softer outlook. Doximity Q4 2026 Earnings Call Transcript
- Negative Sentiment: The stock also faced added caution from an insider sale earlier in the week, though it was disclosed as part of a pre-arranged 10b5-1 plan and tax withholding related to equity vesting. Insider Trade Disclosure
Wall Street Analysts Forecast Growth
A number of analysts recently commented on the stock. Zacks Research upgraded shares of Doximity from a "strong sell" rating to a "hold" rating in a research note on Tuesday, April 21st. Robert W. Baird restated a "neutral" rating and set a $18.00 price objective (down from $40.00) on shares of Doximity in a research note on Thursday. Barclays decreased their price objective on shares of Doximity from $63.00 to $38.00 and set an "overweight" rating for the company in a research note on Wednesday, February 11th. Canaccord Genuity Group set a $34.00 price objective on shares of Doximity and gave the company a "buy" rating in a research note on Monday, February 9th. Finally, Royal Bank Of Canada restated an "outperform" rating and set a $44.00 price objective on shares of Doximity in a research note on Monday, March 9th. Two research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and twelve have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.20.
Read Our Latest Report on Doximity
Institutional Trading of Doximity
Several institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. lifted its stake in Doximity by 4.1% during the 4th quarter. Vanguard Group Inc. now owns 13,285,485 shares of the company's stock valued at $588,281,000 after acquiring an additional 518,916 shares during the period. William Blair Investment Management LLC increased its holdings in shares of Doximity by 11.7% during the 3rd quarter. William Blair Investment Management LLC now owns 5,829,169 shares of the company's stock valued at $426,404,000 after purchasing an additional 609,775 shares in the last quarter. Capital World Investors increased its holdings in shares of Doximity by 5.1% during the 4th quarter. Capital World Investors now owns 5,654,875 shares of the company's stock valued at $250,398,000 after purchasing an additional 273,444 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of Doximity by 6.2% during the 3rd quarter. Franklin Resources Inc. now owns 3,357,505 shares of the company's stock valued at $245,601,000 after purchasing an additional 194,912 shares in the last quarter. Finally, Invesco Ltd. increased its holdings in shares of Doximity by 4.2% during the 4th quarter. Invesco Ltd. now owns 2,426,819 shares of the company's stock valued at $107,460,000 after purchasing an additional 98,519 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.
About Doximity
(
Get Free Report)
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
